Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,548,569 papers from all fields of science
Search
Sign In
Create Free Account
GSK 2334470
Known as:
GSK-2334470
, GSK2334470
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (2)
Indazoles
Pyrimidines
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
IGF-1 protects SH-SY5Y cells against MPP+-induced apoptosis via PI3K/PDK-1/Akt pathway
Chanyang Kim
,
Seungjoon Park
Endocrine Connections
2018
Corpus ID: 3874119
Insulin-like growth factor (IGF)-1 is a well-known anti-apoptotic pro-survival factor and phosphatidylinositol-3-kinase (PI3K…
Expand
2017
2017
Relationship between PDK1 and contraction in carotid arteries in Goto-Kakizaki rat, a spontaneous type 2 diabetic animal model.
Shun Watanabe
,
T. Matsumoto
,
K. Taguchi
,
Tsuneo Kobayashi
Canadian Journal of Physiology and Pharmacology
2017
Corpus ID: 21527067
We studied the relationship between 3-phosphoinositide-dependent protein kinase 1 (PDK1) and contractions induced by serotonin…
Expand
2017
2017
Abstract P3-03-05: PI3K/PDK1 mediates resistance to CDK4/6 inhibitors through dysregulation of S-phase cyclins/cyclin dependent kinases (CDKs)
V. Jansen
,
L. Formisano
,
+5 authors
C. Arteaga
2017
Corpus ID: 78898733
Background: CDK4/6 inhibitors in combination with antiestrogens are approved for the treatment of ER+ advanced breast cancer…
Expand
2016
2016
Abstract PD2-06: Inhibition of 3-phosphoinositide dependent protein kinase 1 (PDK1) synergizes with CDK4/6 inhibitors against ER-positive breast cancer
V. Jansen
,
N. Bhola
,
+4 authors
C. Arteaga
2016
Corpus ID: 77313567
Background: Dysregulation in cell cycle checkpoints is common in cancer. Small molecule inhibitors that target the CDK4/6…
Expand
2014
2014
The phosphoinositide-dependent protein kinase 1 inhibitor, UCN-01, induces fragmentation: possible role of metalloproteinases.
R. Alcántara-Hernández
,
Aurelio Hernández‐Méndez
,
J. García-Sáinz
European Journal of Pharmacology
2014
Corpus ID: 35059680
2014
2014
Abstract 59: PDK1 in melanoma development and metastasis
M. Scortegagna
,
Chelsea M. Ruller
,
+8 authors
Z. Ronai
2014
Corpus ID: 57182543
Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA Phosphoinositide-dependent kinase-1 (PDK-1) is a serine…
Expand
2011
2011
For a PDK1 inhibitor, the substrate matters.
Z. Knight
Biochemical Journal
2011
Corpus ID: 20335883
More than 20 protein kinases are directly activated by 3-phosphoinositide-dependent kinase 1 (PDK1), which is a central component…
Expand
2010
2010
Characterization of GSK 2334470 , a novel and highly specific inhibitor of PDK 1
Ayaz Najafov
,
E. Sommer
,
J. Axten
,
M. P. DeYoung
,
D. Alessi
2010
Corpus ID: 39187234
PDK1 (3-phosphoinositide-dependent protein kinase 1) activates a group of protein kinases belonging to the AGC [PKA (protein…
Expand
2010
2010
Abstract LB-42: PDK1 knockdown selectively inhibits growth of cancer cells harboring activating mutations involved in MAPK signaling
M. P. DeYoung
,
Christine M. Gardiner
,
A. Chadderton
,
J. Medina
,
J. Axten
,
S. Rabindran
2010
Corpus ID: 76383390
Phosphoinositide-dependent protein kinase-1 (PDK1) is a master regulator of the AGC family of kinases and an integral component…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE